Colistin versus meropenem in the empirical treatment of ventilator-associated #pneumonia (Magic Bullet study) @Crit_Care | #ECM https://t.co/fCa8fsq6uQ
Magic Bullet Study: Colistin Versus Meropenem in the Empirical Treatment of Ventilator-Associated Pneumonia https://t.co/nipAiAUdGI
RT @SyamhaninA: Interesting study to take note. Perhaps this can be one of the reason why we should move towards polymyxin B for VAP due to…
Interesting study to take note. Perhaps this can be one of the reason why we should move towards polymyxin B for VAP due to poor penetration of colistin. https://t.co/NjYi3pmMDF @edenhelmi
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial. https://t.co/xXiZSe2WcO #cre #crkp
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial | Critical Care | Full Text https://t.co/NruDKeYKwN #cre #crkp
Colistin versus meropenem in the empirical treatment of ventilator-associated #pneumonia (Magic Bullet study) @Crit_Care | #ECM https://t.co/fCa8fsq6uQ
Colistin versus meropenem in the empirical treatment of ventilator-associated #pneumonia (Magic Bullet study) @Crit_Care | #ECM https://t.co/FRvCfxjWTl
RT @ID_ethics: Scary title of this study - is the Magic Bullet supposed to be colistin? a >50 year old drug that we stopped using because i…
Scary title of this study - is the Magic Bullet supposed to be colistin? a >50 year old drug that we stopped using because it was too toxic and not very effective? This study, its results, and the "magic bullet" metaphor, shows how desperate the situati
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study) #CriticalCare https://t.co/X0v525DX2Z
RT @JacobLazarusMD: Empiric polymxns for HAP/VAP? Multicenter trial shows increased tox, similar outcomes to penems in region of high MDR e…
RT @boticariors: See our last paper. Finally published. Congrats to all involved. Great work ! #antimicrobialresistance #infectiousdisease…
RT @boticariors: See our last paper. Finally published. Congrats to all involved. Great work ! #antimicrobialresistance #infectiousdisease…
See our last paper. Finally published. Congrats to all involved. Great work ! #antimicrobialresistance #infectiousdiseases Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an in… https://t.co/f
RT @JacobLazarusMD: Empiric polymxns for HAP/VAP? Multicenter trial shows increased tox, similar outcomes to penems in region of high MDR e…
Empiric polymxns for HAP/VAP? Multicenter trial shows increased tox, similar outcomes to penems in region of high MDR endemicity. IDSA guidelines weakly recommend polymixins in this setting. Too toxic and ?ineffective to use empirically IV for PNA https://
RT @notthewongrx: Colistin (CST+LVX vs. MEM+LVX) not "Magic Bullet" in empiric tx of "late" VAP (>96h MV or <96 MV+prev 5-day course ABX).…
RT @ICU_Management: Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an invest…
RT @notthewongrx: Colistin (CST+LVX vs. MEM+LVX) not "Magic Bullet" in empiric tx of "late" VAP (>96h MV or <96 MV+prev 5-day course ABX).…
RT @notthewongrx: Colistin (CST+LVX vs. MEM+LVX) not "Magic Bullet" in empiric tx of "late" VAP (>96h MV or <96 MV+prev 5-day course ABX).…
RT @notthewongrx: Colistin (CST+LVX vs. MEM+LVX) not "Magic Bullet" in empiric tx of "late" VAP (>96h MV or <96 MV+prev 5-day course ABX).…
RT @notthewongrx: Colistin (CST+LVX vs. MEM+LVX) not "Magic Bullet" in empiric tx of "late" VAP (>96h MV or <96 MV+prev 5-day course ABX).…
RT @matthieulegrand: Reminder: colistin is highly nephrotoxic ! Colistin versus meropenem in the empirical treatment of ventilator-associat…
RT @ICU_Management: Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an invest…
Colistin (CST+LVX vs. MEM+LVX) not "Magic Bullet" in empiric tx of "late" VAP (>96h MV or <96 MV+prev 5-day course ABX). Fails non-inferiority margin in RCT eval 28-day all-cause ☠️ and ☝️ risk of renal failure. @mmPharmD @n_mercuro #IDtwitter #Phar
RT @ICU_Management: Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an invest…
RT @matthieulegrand: Impact of MDR bacteria on outocome in the ICU probably (partially) driven by the increase use of colistin : https://t.…
Impact of MDR bacteria on outocome in the ICU probably (partially) driven by the increase use of colistin : https://t.co/USyHkYz3GA
Reminder: colistin is highly nephrotoxic ! Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study) https://t.co/dfUWJZWYmv
RT @ICU_Management: Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an invest…
Los que usan colistina empirica para la #NAV son el equivalente a los que usan ceftriaxona para las faringitis virales https://t.co/FjkF8e76XC
RT @ICU_Management: Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an invest…
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial https://t.co/ZsDkremh5E